Clinical Trial Update: Pilot Study of Cabazitaxel and Paclitaxel in HER2 Negative Breast Cancer [Phase 2]

View source ↗

Summary

Pilot Phase 2 trial updating on cabazitaxel and paclitaxel in HER2-negative metastatic breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Cabazitaxel (cabazitaxel)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust | Conditions: HER2 Negative Metastatic Breast Cancer | Phase 2 | Status: UNKNOWN